论文部分内容阅读
“十八反”是中药配伍禁忌的核心内容,对中医临床安全用药起着重要的指导作用。自1963年始,历版《中华人民共和国药典》(简称《中国药典》)均收录了“十八反”的内容。然而,反药能否同用,古今一直存有争议。为了解基层医院对“十八反”中附子半夏同方配伍应用的现状,笔者调查了华北某县中医院及9所乡镇卫生院2008年1月～2011年2月的中药处方共78 238首,进行整理归纳,结果报道如下。
“Anti-18” is the core content of incompatibility of traditional Chinese medicine, plays an important guiding role in the clinical safety of traditional Chinese medicine. Since 1963, the Chinese version of the “Pharmacopoeia of the People’s Republic of China” (“the Chinese Pharmacopoeia”) have included “anti-18” content. However, whether anti-drug can be used together has always been controversial. In order to understand the current situation of grassroots hospital on the application of Radix Aconiti Pinellia in compatibility with “Eighteen Antibodies”, the author investigated a total of 78 prescriptions of traditional Chinese medicine from January 2008 to February 2011 in a county Chinese medicine hospital and nine township hospitals in North China 238, summarized, the results reported below.